Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq:BNGO) today announced its participation in the International Society for Stem Cell Research (ISSCR) Annual Meeting 2024 with a broad range of content covering the utility of optical genome mapping (OGM) for research, development, and manufacturing applications in stem cell therapy. ISSCR’s annual meeting brings together industry, medical, and academic professionals to discuss advances in stem cell research and regenerative medicine. The ISSCR conference will be held July 10-13, 2024, in Hamburg, Germany.